Cargando…
Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours
BACKGROUND: The DNA repair protein O(6)-methylguanine-DNA methyltransferase (MGMT) reverses the O(6)-methylguanine (O(6)-meG) lesion induced by dacarbazine. Depletion of MGMT can be achieved using O(6)-meG pseudosubstrates. Herein, we report the first phase I experience of the novel O(6)-meG pseudos...
Autores principales: | Tawbi, H A, Villaruz, L, Tarhini, A, Moschos, S, Sulecki, M, Viverette, F, Shipe-Spotloe, J, Radkowski, R, Kirkwood, J M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171007/ https://www.ncbi.nlm.nih.gov/pubmed/21811257 http://dx.doi.org/10.1038/bjc.2011.285 |
Ejemplares similares
-
Lomeguatrib Increases the Radiosensitivity of MGMT Unmethylated Human Glioblastoma Multiforme Cell Lines
por: Kirstein, Anna, et al.
Publicado: (2021) -
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma
por: Kefford, R F, et al.
Publicado: (2009) -
LncRNA POU3F3 Contributes to Dacarbazine Resistance of Human Melanoma Through the MiR-650/MGMT Axis
por: Wu, Kai, et al.
Publicado: (2021) -
Broadband Ge/SiGe quantum dot photodetector on pseudosubstrate
por: Yakimov, Andrew, et al.
Publicado: (2013) -
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib
por: Watson, A J, et al.
Publicado: (2009)